Royce & Associates’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.6M | Sell |
553,197
-28,014
| -5% | -$530K | 0.09% | 340 |
|
|
2025
Q4 | $11M | Buy |
581,211
+176,817
| +44% | +$2.96M | 0.11% | 283 |
|
|
2025
Q3 | $5.88M | Sell |
404,394
-374,210
| -48% | -$5.33M | 0.06% | 439 |
|
|
2025
Q2 | $15.2M | Buy |
778,604
+295,273
| +61% | +$5.25M | 0.16% | 196 |
|
|
2025
Q1 | $8.58M | Sell |
483,331
-955
| -0.2% | -$20.6K | 0.09% | 324 |
|
|
2024
Q4 | $10.4M | Buy |
484,286
+91,000
| +23% | +$2.21M | 0.1% | 308 |
|
|
2024
Q3 | $12.3M | Buy |
393,286
+1,000
| +0.3% | +$24.9K | 0.11% | 257 |
|
|
2024
Q2 | $6.09M | Sell |
392,286
-146,012
| -27% | -$1.76M | 0.06% | 436 |
|
|
2024
Q1 | $5.7M | Buy |
538,298
+194,593
| +57% | +$1.95M | 0.05% | 467 |
|
|
2023
Q4 | $4.12M | Sell |
343,705
-717,850
| -68% | -$5.88M | 0.04% | 527 |
|
|
2023
Q3 | $7.43M | Buy |
1,061,555
+270,950
| +34% | +$2.5M | 0.08% | 375 |
|
|
2023
Q2 | $6.72M | Buy |
790,605
+358,100
| +83% | +$2.99M | 0.07% | 427 |
|
|
2023
Q1 | $3.95M | Buy |
432,505
+332,400
| +332% | +$4.25M | 0.04% | 540 |
|
|
2022
Q4 | $1.14M | Sell |
100,105
-67,000
| -40% | -$993K | 0.01% | 735 |
|
|
2022
Q3 | $2.84M | Sell |
167,105
-48,650
| -23% | -$1.04M | 0.03% | 576 |
|
|
2022
Q2 | $4.63M | Sell |
215,755
-66,300
| -24% | -$1.84M | 0.05% | 493 |
|
|
2022
Q1 | $10.4M | Buy |
282,055
+5,000
| +2% | +$195K | 0.09% | 346 |
|
|
2021
Q4 | $12.6M | Buy |
277,055
+52,535
| +23% | +$2.74M | 0.09% | 343 |
|
|
2021
Q3 | $14.2M | Sell |
224,520
-92,600
| -29% | -$7.05M | 0.11% | 311 |
|
|
2021
Q2 | $29M | Buy |
317,120
+37,500
| +13% | +$2.98M | 0.2% | 147 |
|
|
2021
Q1 | $19M | Sell |
279,620
-175,779
| -39% | -$13.6M | 0.13% | 267 |
|
|
2020
Q4 | $33M | Sell |
455,399
-11,079
| -2% | -$642K | 0.27% | 85 |
|
|
2020
Q3 | $17.7M | Sell |
466,478
-87,900
| -16% | -$2.97M | 0.19% | 139 |
|
|
2020
Q2 | $19.6M | Sell |
554,378
-25,482
| -4% | -$725K | 0.22% | 121 |
|
|
2020
Q1 | $12.7M | Buy |
579,860
+35,298
| +6% | +$791K | 0.17% | 158 |
|
|
2019
Q4 | $11.7M | Buy |
544,562
+217,138
| +66% | +$4.98M | 0.1% | 276 |
|
|
2019
Q3 | $7.4M | Buy |
327,424
+187,112
| +133% | +$5.18M | 0.07% | 380 |
|
|
2019
Q2 | $5.05M | Sell |
140,312
-99,800
| -42% | -$3.19M | 0.05% | 485 |
|
|
2019
Q1 | $7.57M | Sell |
240,112
-135,400
| -36% | -$3.94M | 0.06% | 400 |
|
|
2018
Q4 | $9.44M | Sell |
375,512
-193,610
| -34% | -$4.97M | 0.08% | 336 |
|
|
2018
Q3 | $16.4M | Sell |
569,122
-297,261
| -34% | -$5.56M | 0.11% | 273 |
|
|
2018
Q2 | $10.6M | Sell |
866,383
-137,204
| -14% | -$1.57M | 0.07% | 373 |
|
|
2018
Q1 | $8M | Buy |
1,003,587
+30,500
| +3% | +$188K | 0.06% | 445 |
|
|
2017
Q4 | $7.14M | Buy |
973,087
+180,300
| +23% | +$1.12M | 0.05% | 495 |
|
|
2017
Q3 | $2.93M | Buy |
792,787
+59,500
| +8% | +$125K | 0.02% | 732 |
|
|
2017
Q2 | $814K | Buy |
733,287
+206,815
| +39% | +$220K | 0.01% | 1001 |
|
|
2017
Q1 | $737K | Buy |
526,472
+100,111
| +23% | +$223K | ﹤0.01% | 1014 |
|
|
2016
Q4 | $1.15M | Buy |
426,361
+178,743
| +72% | +$619K | 0.01% | 911 |
|
|
2016
Q3 | $879K | Buy |
247,618
+112,873
| +84% | +$518K | 0.01% | 946 |
|
|
2016
Q2 | $582K | Buy |
134,745
+48,828
| +57% | +$226K | ﹤0.01% | 966 |
|
|
2016
Q1 | $426K | Buy |
85,917
+11,503
| +15% | +$58.9K | ﹤0.01% | 1001 |
|
|
2015
Q4 | $476K | Buy |
74,414
+13,500
| +22% | +$73.5K | ﹤0.01% | 1015 |
|
|
2015
Q3 | $254K | Buy |
60,914
+29,865
| +96% | +$197K | ﹤0.01% | 1095 |
|
|
2015
Q2 | $202K | Buy |
31,049
+8,800
| +40% | +$47.8K | ﹤0.01% | 1134 |
|
|
2015
Q1 | $123K | Buy |
22,249
+10,800
| +94% | +$71.2K | ﹤0.01% | 1149 |
|
|
2014
Q4 | $83K | Buy |
+11,449
| New | +$76.8K | ﹤0.01% | 1232 |
|
Other funds holding CDNA
AIM
DM
B
VCM
GS
